Discovery of (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide (BMS-742413): A potent human CGRP antagonist with superior safety profile for the treatment of migraine through intranasal delivery

Publication | Open Access

DOI Full Paper Access

Citations

References

2013

Year

Prasad V. Chaturvedula, Stephen E. Mercer, Sokhom S. Pin, George Thalody, Cen Xu, Charlie M. Conway, Deborah Keavy, Laura J. Signor, Glenn H. Cantor, Neil Mathias,

Bioorganic & Medicinal Chemistry Letters

Superior Safety ProfileMedicinal ChemistryMedicinePharmacological AgentPharmacotherapyIntranasal DeliveryPharmacologyPharmaceutical ChemistryDrug Discovery